Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cassava Sciences Inc (NQ: SAVA )

4.420 -22.060 (-83.31%)
Streaming Delayed Price Updated: 1:56 PM EST, Nov 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cassava Sciences Inc

< Previous 1 2
...
27 28 29 30 31 32 33 34 Next >
Cassava Sciences Stock Could Be Worth $900 After Its Upcoming Alzheimer’s Results
Cassava Sciences stock could jump with its upcoming Alzheimer's results. SAVA stock options show the lofty expectations investors have. 
Via InvestorPlace
An Unforgettable Week For Alzheimer's Treatment Stocks: Two Of Our Recent Top Names Spike On News Of Potentially Promising Treatments
Screen capture via IGC's healthcare subsidiary Hyalolex. "Drops of Clarity" is their just-patented Alzheimer's treatment. Two Stocks Spike On Alzheimer... 
Via Benzinga
Update On A Bear-Proof Portfolio: The Portfolio We Presented Earlier This Week Is Off To A Fast Start
Japanese gameshow contestant versus bear. Image via TMZ. Bear-Proof Portfolio Update Here's the "bear-proof" portfolio we presented in our pre-market post on... 
Via Benzinga
Why Annovis Stock Is Bucking The Trend In Alzheimer's — And Two Others To Watch
Annovis bucked the trend depressing Alzheimer's stocks on Friday as ANVS stock touched a record high while SAVA stock and INMB stock fell. 
Via Investor's Business Daily
An Unforgettable Week For Alzheimer's Treatment Stocks
Two of our recent top stocks spiked on news of potentially promising Alzheimer's treatments this week. They're both risky names, so we look at how to hold them without losing your shirt. 
Via Talk Markets
The Daily Biotech Pulse: Acorda Spikes On Distribution Deal, Alzamend Soars On Data, Pfizer-BioNTech To Supply More Vaccine Doses, 3 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 22) Bio-Techne Corporation (... 
Via Benzinga
Cassava Sciences Stock Soars In Anticipation Of Alzheimer's Data: A Technical Analysis
On Thursday, Cassava Sciences, Inc (NASDAQ: SAVA) smashed through a resistance level at $117.54, made 21 years ago between its initial public offering date of June 14,... 
Via Benzinga
Update On A Bear-Proof Portfolio
A quick update on the portfolio we presented here in our pre-market post on Tuesday. 
Via Talk Markets
The Daily Biotech Pulse: FDA Nod For Merck-Eisai, Seres' Ulcerative Colitis Drug Flunks Midstage Study, Pfizer To Invest In Arvinas, AbSci IPO
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 21) Biohaven Pharmaceutical... 
Via Benzinga
Exposures Product Safety
2 High-Risk, High-Reward Stocks That Could Go to the Moon
Risk-averse investors may want to look elsewhere. 
Via The Motley Fool
61 Biggest Movers From Yesterday
Gainers Chembio Diagnostics, Inc. (NASDAQ: CEMI) shares surged 159.2% to close at $5.34 on Wednesday after the company received a $28.3 million purchase order from Brazil's... 
Via Benzinga
Here's Why Cassava Sciences Is Surging Today
Investors are excited about upcoming presentations scheduled for the annual Alzheimer's Association International Conference. 
Via The Motley Fool
Exposures Product Safety
SAVA Stock: Two Dates Cassava Investors Need to Mark on Their Calendars
SAVA stock is flying upward today as investors clamor to hear information around two new products. Investors should save two upcoming dates. 
Via InvestorPlace
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers Chembio Diagnostics (NASDAQ:CEMI) stock rose 189.72% to $5.97 during Wednesday's regular session. Trading volume for Chembio Diagnostics's stock is 265.3... 
Via Benzinga
38 Stocks Moving In Wednesday's Mid-Day Session
Gainers Chembio Diagnostics, Inc. (NASDAQ: CEMI) shares jumped 218.7% to $6.57 after the company received a $28.3 million purchase order from Brazil's Bio-Manguinhos to... 
Via Benzinga
Building A Bear-Proof Portfolio: Investing Safely Up As The Fear & Greed Index Approaches Early 2020 Levels.
Market Fear Gauge Approaches 2020 Levels As ZeroHedge reported on Monday, the Fear & Greed gauge has approached early 2020 levels. Screen capture via... 
Via Benzinga
Here's Why Cassava Sciences Is Up 1,152% in the First Half of 2021
This small-cap biotech has shot up in value as the company's Alzheimer's drug makes it way through clinical trials. 
Via The Motley Fool
Is Now The Time To Buy Stock In Cassava Sciences, Facebook Or Apple?
One of the most common questions traders have about stocks is “Why Is It Moving?” That’s why Benzinga created the Why I... 
Via Benzinga
Why Is Cassava Sciences Stock Soaring in 2021?
The stock market is excited by the clinical trial results for its Alzheimer's drug. 
Via The Motley Fool
10 Biggest Price Target Changes For Tuesday
Citigroup boosted International Business Machines Corporation (NYSE: 
Via Benzinga
Building A Bear-Proof Portfolio
How to invest confidently as the Fear & Greed gauge hits early 2020 fear levels. 
Via Talk Markets
Understanding Cassava Sciences's Unusual Options Activity
Cassava Sciences (NASDAQ:SAVA) shares experienced unusual options activity on Friday. The stock price moved down to $79.73 following the option alert. Sentiment: BEARISH Option... 
Via Benzinga
54 Biggest Movers From Yesterday
Gainers Sight Sciences, Inc. (NASDAQ: SGHT) shares jumped 39.6% to settle at $33.50 on Thursday as the company priced its IPO at $24 per share. Cinedigm Corp. (NASDAQ: CIDM)... 
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
Why Cassava Sciences Stock Moved Higher Monday
The biotech stock bounced back big Monday after tumbling on Friday. 
Via The Motley Fool
38 Stocks Moving In Monday's Mid-Day Session
Gainers State Auto Financial Corporation (NASDAQ: STFC) shares jumped 189.5% to $49.96 after the company agreed to be acquired by Liberty Mutual Insurance for $52 per share in... 
Via Benzinga
24 Stocks Moving in Monday's Pre-Market Session
Gainers SGOCO Group, Ltd. (NASDAQ: SGOC) shares rose 67.7% to $16.42 in pre-market trading after jumping around 280% on Friday. MER Telemanagement Solutions Ltd. (NASDAQ: MTSL)... 
Via Benzinga
64 Biggest Movers From Friday
Gainers Sentage Holdings Inc. (NASDAQ: SNTG) shares surged 597.8% to settle at $34.89 on Friday as the company priced its IPO at $5 per share. SGOCO Group, Ltd. (NASDAQ: SGOC)... 
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
Biogen Stock Drags On Alzheimer's Players As FDA Requests Review Of Aduhelm Approval
Biogen stock tumbled Friday after the FDA requested an independent review of the process that led to its recent Alzheimer's approval. 
Via Investor's Business Daily
Exposures Product Safety
Follow the Money to Find Out What's Working This Year
The notorious dip-buyers have been aggressively supporting this market ever since the pandemic low point last year. If they become fully invested, the flow of new money into the market could stop. 
Via Talk Markets
Neurodegenerative Disease And Cancer Stocks Among Top Biotech Gainers In 2021
Biotech stocks underperformed the broader market in the first half of 2021, with the iShares Nasdaq Biotechnology ETF IBB advancing about 8% year-to-date compared to the roughly 14% gain for the S&P... 
Via Talk Markets
Topics Stocks
Exposures US Equities
< Previous 1 2
...
27 28 29 30 31 32 33 34 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.